Abbott’s Q2 Medical Device And Diagnostic Sales Surpass 2019 Levels

Abbott expects the ongoing recovery of medical procedure volumes to continue even as new virus variants are causing COVID-19 cases to increase in some geographies.

Earning Report Q2

Abbott’s medical device and diagnostic sales in the second quarter of 2021 not only recovered from the worst days of the pandemic in 2020, but exceeded pre-pandemic levels.

The company’s medical device sales totaled $3.67bn in the second quarter, representing a 45

More from In Vitro Diagnostics

More from Diagnostics